109906
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
桑色素对感染后咳嗽幼鼠肠道菌群及 ERK 信号通路调节作用的机制研究
Authors Luo J, Zhang D, Zhang M, Chen Y, Ding Y
Received 28 June 2025
Accepted for publication 8 October 2025
Published 19 November 2025 Volume 2025:18 Pages 16093—16109
DOI https://doi.org/10.2147/JIR.S550219
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Tara Strutt
Jing Luo,1 Dan Zhang,1 Miaomiao Zhang,1 Yiqiang Chen,1 Yi Ding2
1Department of Chinese Medicine, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, Guangzhou, People’s Republic of China; 2Department of Physical Medicine and Rehabilitation, Changsha Social Work College, Changsha, Hunan, People’s Republic of China
Correspondence: Yi Ding, Department of Physical medicine and rehabilitation, Changsha Social Work College, Changsha, Hunan, People’s Republic of China, 410004, Email zyk20240403@163.com
Background: Post-infectious cough (PIC) is a leading cause of chronic cough in children, often persisting after respiratory infections and significantly impairing quality of life. Current therapies, such as montelukast sodium (MAS), offer only partial symptom relief and do not target the underlying inflammatory and microbiota-driven mechanisms. Emerging evidence suggests that the lung–gut axis, ERK pathway activation, and cytokine–microbiota interactions are central to PIC pathogenesis. Morusin, a prenylated flavonoid from Morus alba, possesses anti-inflammatory and barrier-protective activities and may uniquely modulate both ERK signaling and gut microbiota, offering mechanistic advantages over conventional treatments.
Methods: A juvenile rat model of PIC was induced by smoke exposure, lipopolysaccharide nasal instillation, and capsaicin atomization. Rats were assigned to control, model, morusin, or MAS groups. Physiological outcomes, histology, and immunostaining were assessed, including body weight, airway resistance, goblet cells, cytokines (IL-4, IL-6, IL-10), and phosphorylated ERK1/2 (p-ERK1/2) in lung and colon tissues. Gut microbiota was profiled via 16S rRNA sequencing, with correlation analyses linking microbial changes to cytokine and signaling profiles.
Results: Morusin improved systemic parameters (body weight, salivary flow, skin hydration), reduced airway hyperreactivity, and normalized anxiety-like behaviors, effects not observed with MAS. Both morusin and MAS reduced lung goblet cell hyperplasia and inflammatory cytokines, but only morusin suppressed p-ERK1/2 in both lung and colon tissues and reshaped the gut microbiota. Morusin enriched beneficial genera (Lactobacillus, Akkermansia) and reduced pro-inflammatory taxa (Ruminococcus, Lachnospiraceae_NK4A136_group). Correlation analyses confirmed strong links between microbial shifts, cytokine balance, and ERK modulation.
Conclusion: Morusin alleviates PIC through systemic, mucosal, and behavioral improvements, combined with unique modulation of gut microbiota and ERK signaling across the lung–gut axis. These findings highlight morusin’s novel mechanistic advantage over MAS and support its potential as a translational therapy for pediatric PIC.
Keywords: morusin, post-infectious cough, air way inflammation, p-ERK, gut microbiota
1Department of Chinese Medicine, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, Guangzhou, People’s Republic of China; 2Department of Physical Medicine and Rehabilitation, Changsha Social Work College, Changsha, Hunan, People’s Republic of China
Correspondence: Yi Ding, Department of Physical medicine and rehabilitation, Changsha Social Work College, Changsha, Hunan, People’s Republic of China, 410004, Email zyk20240403@163.com
Background: Post-infectious cough (PIC) is a leading cause of chronic cough in children, often persisting after respiratory infections and significantly impairing quality of life. Current therapies, such as montelukast sodium (MAS), offer only partial symptom relief and do not target the underlying inflammatory and microbiota-driven mechanisms. Emerging evidence suggests that the lung–gut axis, ERK pathway activation, and cytokine–microbiota interactions are central to PIC pathogenesis. Morusin, a prenylated flavonoid from Morus alba, possesses anti-inflammatory and barrier-protective activities and may uniquely modulate both ERK signaling and gut microbiota, offering mechanistic advantages over conventional treatments.
Methods: A juvenile rat model of PIC was induced by smoke exposure, lipopolysaccharide nasal instillation, and capsaicin atomization. Rats were assigned to control, model, morusin, or MAS groups. Physiological outcomes, histology, and immunostaining were assessed, including body weight, airway resistance, goblet cells, cytokines (IL-4, IL-6, IL-10), and phosphorylated ERK1/2 (p-ERK1/2) in lung and colon tissues. Gut microbiota was profiled via 16S rRNA sequencing, with correlation analyses linking microbial changes to cytokine and signaling profiles.
Results: Morusin improved systemic parameters (body weight, salivary flow, skin hydration), reduced airway hyperreactivity, and normalized anxiety-like behaviors, effects not observed with MAS. Both morusin and MAS reduced lung goblet cell hyperplasia and inflammatory cytokines, but only morusin suppressed p-ERK1/2 in both lung and colon tissues and reshaped the gut microbiota. Morusin enriched beneficial genera (Lactobacillus, Akkermansia) and reduced pro-inflammatory taxa (Ruminococcus, Lachnospiraceae_NK4A136_group). Correlation analyses confirmed strong links between microbial shifts, cytokine balance, and ERK modulation.
Conclusion: Morusin alleviates PIC through systemic, mucosal, and behavioral improvements, combined with unique modulation of gut microbiota and ERK signaling across the lung–gut axis. These findings highlight morusin’s novel mechanistic advantage over MAS and support its potential as a translational therapy for pediatric PIC.
Keywords: morusin, post-infectious cough, air way inflammation, p-ERK, gut microbiota